Related Experiment Video
Updated: Jul 3, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Perioperative microemboli and platelet aggregation in patients undergoing carotid endarterectomy
J Mathys Vogten1, Wim B M Gerritsen, Rob G A Ackerstaff
1Department of Vascular Surgery, St Antonius Hospital, Nieuwegein, The Netherlands. jmvogten@hotmail.com
Insights
Platelet aggregation increases during carotid endarterectomy (CEA) despite antiplatelet drugs. Clopidogrel use was linked to fewer microemboli, suggesting a potential benefit in reducing perioperative complications.
Area of Science:
- Vascular Surgery
- Cardiovascular Research
- Hematology
Background:
- Platelet aggregation remains elevated in carotid endarterectomy (CEA) patients even with heparin. The link between this aggregation and perioperative microemboli is not fully understood.
- Antiplatelet therapies like aspirin and clopidogrel are commonly used in CEA patients, but their impact on intraoperative platelet activity and microemboli requires further investigation.
Purpose of the Study:
- To investigate the correlation between increased platelet aggregation and perioperative microemboli occurrence in CEA patients.
- To evaluate the effect of aspirin and clopidogrel on platelet aggregation and microemboli during CEA.
Main Methods:
- Prospective study of 27 CEA patients, assessing platelet aggregation and P-selectin expression at multiple time points.
- Utilized Transcranial Doppler (TCD) monitoring to quantify perioperative microemboli.
- Compared outcomes between patients receiving aspirin alone versus aspirin with clopidogrel.
Main Results:
- Platelet aggregation significantly increased post-heparinization in both aspirin and clopidogrel groups (p < .01 and p < .05).
- A trend towards increased P-selectin expression was observed post-heparinization.
- Patients on clopidogrel exhibited significantly fewer microemboli compared to those on aspirin alone (4.1 +/- 2.3 vs 17.6 +/- 18.2; p < .01).
- Higher baseline platelet aggregation showed a tendency towards increased microemboli (p = .08).
Conclusions:
- Platelet aggregation transiently increases during CEA, even with antiplatelet agents.
- Clopidogrel use is associated with a reduction in perioperative microemboli during CEA.
- Further research is needed to clarify the relationship between these findings and the risk of thromboembolic complications post-CEA.
Abstract:
In carotid endarterectomy (CEA) patients, platelet aggregation is increased despite heparinization. We investigated whether this phenomenon correlates with the occurrence of perioperative microemboli. Of 27 CEA patients, 18 (67%) used aspirin and 9 also used clopidogrel. Blood was collected at multiple time points before, during, and after CEA. Platelet aggregation and P-selectin expression were determined. Transcranial Doppler monitoring was used to measure microemboli. Platelet aggregation showed a significant increase 5 minutes postheparinization compared with preheparinization (19.7 +/- 2.8% vs 8.9 +/- 0.9% in the aspirin group and 22.5 +/- 4.4% vs 8.7 +/- 1.2% in the clopidogrel group; p < .01 and p < .05, respectively). P-selectin expression showed a tendency to increase postheparinization in both groups (p = .07 and p = .09, respectively). The number of microemboli ranged from 0 to 50. Clopidogrel patients displayed fewer microemboli than aspirin patients (4.1 +/- 2.3 vs 17.6 +/- 18.2; p < .01). Patients with a high number of microemboli displayed had a tendency toward higher baseline platelet aggregation than patients with a low number of microemboli (p = .08). In conclusion, platelet aggregation is transiently increased during CEA despite the administration of antiplatelet agents. Clopidogrel is associated with a decreased number of perioperative microemboli. The exact relationships between these findings, postoperative microemboli formation, and the risk for thromboembolic complications after CEA remain to be determined.
Related Concept Videos
Aneurysm IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease V: Postoperative Nursing Management
